Glutamine repeats and neurodegenerative diseases: molecular aspects
- 1 February 1999
- journal article
- review article
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 24 (2) , 58-63
- https://doi.org/10.1016/s0968-0004(98)01350-4
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodiesProceedings of the National Academy of Sciences, 1998
- Characterization of an Expanded Glutamine Repeat Androgen Receptor in a Neuronal Cell Culture SystemNeurobiology of Disease, 1997
- Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansionNature Genetics, 1997
- Episodic Ataxia Type 2 (EA2) and Spinocerebellar Ataxia Type 6 (SCA6) Due to CAG Repeat Expansion in the CACNA1A Gene on Chromosome 19pHuman Molecular Genetics, 1997
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- SCA6 is caused by moderate CAG expansion in the alpha1A-voltage- dependent calcium channel geneHuman Molecular Genetics, 1997
- Neural Precursor Cells: Applications for the Study and Repair of the Central Nervous SystemNeurobiology of Disease, 1997
- Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channelNature Genetics, 1997
- ReviewBiological Chemistry Hoppe-Seyler, 1996
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993